Andrew Taylor Lawrence, the Chief Financial Officer of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), recently acquired 1,000 shares of the company's common stock. The purchase, made on December 19, was executed at a weighted average price of $4.83 per share, totaling approximately $4,830. The transaction comes as the stock trades near its 52-week low of $4.22, having declined about 9% in the past week. This transaction increases Lawrence's total holdings to 344,960 shares. The shares were acquired in multiple transactions, with prices ranging from $4.81 to $4.89. According to InvestingPro data, the company maintains impressive gross profit margins of 93% and holds more cash than debt on its balance sheet. For deeper insights into insider trading patterns and additional financial metrics, InvestingPro offers 8 more key tips about OBIO's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.